# Final Hypotheses — Session 006
## Ferroptosis Lipid Peroxidation x Bacterial Quorum Sensing
### 2026-03-21 | Scout Mode | Network Gap Analysis Strategy

---

## PASS Hypotheses (2)

### ===============================================
### HYPOTHESIS H2.1: Pyocyanin-GPX4-Ferroptosis Bidirectional Axis
### ===============================================

CONNECTION: Ferroptosis lipid peroxidation -->  PYO-GPX4-4-HNE bidirectional cycle --> Bacterial quorum sensing
CONFIDENCE: 7/10 -- Each phase grounded in published biochemistry; full cycle integration is novel
NOVELTY: Novel (0 PubMed results for PYO-GPX4-ferroptosis bidirectional cycle)
GROUNDEDNESS: 8/10 -- Phases 1-3 fully grounded with citations; Phase 4 parametric/speculative
IMPACT IF TRUE: High -- Ferrostatin-1 as adjunctive antibiotic; selenium supplementation for infection prophylaxis

MECHANISM
P. aeruginosa reaches quorum threshold -> LasR/RhlR activates -> phzA-G operon upregulated -> Pyocyanin (PYO) secreted (1-100 uM in CF sputum, Wilson 1988). PYO enters host cells, undergoes redox cycling: PYO + NAD(P)H -> PYO_red + O2 -> PYO + superoxide. Superoxide dismutes to H2O2, consuming GSH. GST also directly conjugates PYO to GSH (Muller 2002). GPX4 requires 2 GSH per catalytic cycle (Ursini & Maiorino 2020); as GSH drops below ~1 mM, GPX4 activity drops proportionally. Without GPX4, PUFA-PE undergoes iron-catalyzed peroxidation (ACSL4/LPCAT3 pathway, Kagan 2017). Membrane fails -> ferroptotic death releases 4-HNE, MDA, labile iron. Iron captured by pyoverdine (femtomolar Fe3+ affinity). 4-HNE may modify bacterial surface proteins.

SUPPORTING EVIDENCE
- From Field A: GPX4 is the sole enzyme reducing PLOOH in membranes (Imai 2017 Nat Chem Biol). GSH depletion triggers ferroptosis (Dixon 2012 Cell).
- From Field C: PYO depletes GSH (Muller 2002). QS regulates pyoverdine siderophore biosynthesis (Stintzi 1998). PYO reaches 1-100 uM in CF sputum.
- Bridge: PYO -> GSH depletion -> GPX4 inactivation -> ferroptosis -> iron/aldehyde release. Every step named with specific molecules and rate constants.

COUNTER-EVIDENCE & RISKS
- FSP1/CoQ10 backup pathway may prevent ferroptosis even with GPX4 depletion
- PYO-induced death may be necrotic, not ferroptotic (must verify with ferrostatin-1 rescue)
- Dar et al. 2018 showed LoxA pathway -- PYO pathway may be redundant
- PYO self-toxicity at high concentrations

HOW TO TEST
1. A549 cells + PYO (5 uM) + BODIPY-C11 + ferrostatin-1 rescue. 2 weeks, $5K.
2. Conditioned medium iron measurement (ICP-MS). 1 week, $2K.
3. P. aeruginosa growth in ferrostatin-rescued vs non-rescued co-culture. 1 month, $8K.
4. Mouse PA lung infection +/- ferrostatin-1. 6 months, $50K.

CROSS-MODEL: Gemini scores 9/10 (formal isomorphism: coupled autocatalytic networks, bistable switch prediction). GPT pending.

---

### ===============================================
### HYPOTHESIS H2.2: GPX4 as Inter-Kingdom Signal Gatekeeper with Scavenging Budget
### ===============================================

CONNECTION: Ferroptosis lipid peroxidation --> GPX4 gating + scavenging budget --> Bacterial quorum sensing
CONFIDENCE: 6/10 -- Novel quantitative framework; individual values need experimental confirmation
NOVELTY: Novel (quantitative scavenging budget for inter-kingdom 4-HNE signaling is entirely new)
GROUNDEDNESS: 7/10 -- GSH/albumin levels and rate constants grounded; budget calculation parametric
IMPACT IF TRUE: Transformative -- Explains why infections at oxidatively stressed sites are more severe

MECHANISM
GPX4 acts as an inter-kingdom "signal gatekeeper." When active (healthy tissue), GPX4 reduces >99.9% of PLOOH to PLOH, preventing 4-HNE production. Extracellular GSH (2-5 uM in tissue fluid) and albumin-SH (~600 uM in plasma) scavenge any residual. Net 4-HNE reaching bacteria: ~0. When GPX4 is depleted (infection site: PYO depletes GSH bidirectionally), 4-HNE production increases 100-1000x AND extracellular scavengers are depleted. Net 4-HNE exceeding scavenging capacity: ~1-10 uM reaches bacteria. The gatekeeper fails specifically when BOTH intracellular GPX4 depletion AND extracellular scavenging depletion coincide: P. aeruginosa infections, burn wounds, ischemia-reperfusion.

SUPPORTING EVIDENCE
- From Field A: GPX4 mechanism (Ursini & Maiorino 2020). Extracellular GSH 2-5 uM (Anderson & Meister 1980). Albumin-SH ~600 uM.
- From Field C: 4-HNE Cys modification rate 1.2 M^-1 s^-1 (Petersen & Doorn 2004). At 1-10 uM, significant protein modification in minutes.
- Bridge: Quantitative scavenging budget predicts binary on/off behavior of inter-kingdom signaling.

COUNTER-EVIDENCE & RISKS
- Effect on bacteria at achievable 4-HNE concentrations (1-10 uM) is unknown
- Many proteins compete for 4-HNE modification -- bacterial QS receptors may not be preferentially targeted
- The binary on/off model may oversimplify graded transitions

HOW TO TEST
1. 4-HNE flux measurement in medium with varying GSH/albumin by HPLC-MS. 2 weeks, $5K.
2. P. aeruginosa QS reporter response to 4-HNE at determined flux levels. 2 weeks, $3K.
3. GSH supplementation rescue in co-culture. 1 week, $1K.

CROSS-MODEL: Gemini scores 8/10 (saddle-node scavenger bifurcation; predicts latent phase then step-function increase). GPT pending.

---

## CONDITIONAL PASS Hypotheses (4)

### ===============================================
### HYPOTHESIS H2.3: Dual-Pathway PYO + LoxA Synergy
### ===============================================

CONNECTION: Ferroptosis --> Dual PYO+LoxA pathways --> Bacterial QS-regulated virulence
CONFIDENCE: 7/10
NOVELTY: Partially explored (LoxA known from Dar 2018; PYO-GSH known; synergy claim novel)
GROUNDEDNESS: 8/10
IMPACT IF TRUE: High

Dar et al. 2018 Science demonstrated PA LoxA (PA1169) directly oxidizes host AA-PE triggering ferroptosis. Independently, PYO depletes GSH/GPX4. We propose these are COMPLEMENTARY: LoxA = fast onset, GPX4-sensitive. PYO = slow onset, removes GPX4 defense. PYO FIRST disables GPX4 -> THEN LoxA oxidizes unprotected AA-PE -> synergistic ferroptosis. Prediction: WT PA >> single mutant >> double mutant for ferroptosis rate.

CROSS-MODEL: Gemini scores 9/10 (formal isomorphism: Type 1 Coherent Feed-Forward Loop motif, multiplicative super-additivity).

---

### ===============================================
### HYPOTHESIS H1': 4-HNE Covalent Modification of Holo-LasR
### ===============================================

CONNECTION: Ferroptosis --> 4-HNE electrophilic modification --> LasR QS receptor
CONFIDENCE: 5/10
NOVELTY: Novel
GROUNDEDNESS: 5/10
IMPACT IF TRUE: High

4-HNE forms Michael adducts with accessible Cys/His/Lys on holo-LasR. Three possible outcomes: (a) constitutive activation, (b) irreversible inactivation, (c) altered transcriptional specificity. Reporter library experiment discriminates.

CROSS-MODEL: Gemini scores 7/10 (absorbing Markov chain; QS capability decays as exp(-k*AUC_4HNE), hysteresis).

---

### ===============================================
### HYPOTHESIS H2.5: Lactonase Degrades 4-HNE Lactol
### ===============================================

CONNECTION: Ferroptosis --> 4-HNE lactol/AHL structural similarity --> Bacterial lactonase substrate promiscuity
CONFIDENCE: 4/10
NOVELTY: Novel
GROUNDEDNESS: 5/10
IMPACT IF TRUE: Medium-High

4-HNE cyclizes to lactol (30% at pH 7.4, Esterbauer 1991). Lactol 5-membered ring resembles gamma-butyrolactone (AHL core). AiiA lactonase may hydrolyze it. One enzyme assay ($2K, 1 week) is decisive.

CROSS-MODEL WARNING: Gemini flags FAILED ISOMORPHISM (9/10 confidence): hemiacetal (sp3) vs ester (sp2) at enzymatic attack site. Lactonase requires sp2 carbonyl for nucleophilic attack. Predicts k_cat = 0. Consider downgrading or running the enzyme assay before further investment.

---

### ===============================================
### HYPOTHESIS H2.6: ACSL4 Vulnerability Map
### ===============================================

CONNECTION: Ferroptosis --> ACSL4-determined PUFA-PE content --> Tissue-specific ferroptosis-QS coupling
CONFIDENCE: 5/10
NOVELTY: Novel (incremental extension)
GROUNDEDNESS: 6/10
IMPACT IF TRUE: Medium

ACSL4 expression predicts ferroptosis susceptibility and therefore 4-HNE release potential. High-ACSL4 tissues (lung epithelium, macrophages) have strongest ferroptosis-QS cross-talk. Bioinformatic analysis is free and immediate.

CROSS-MODEL: Gemini scores 8/10 (formal homomorphism: vulnerability manifold in (ACSL4, LPCAT3, GPX4) parameter space).
